Patents by Inventor Peter Kraass

Peter Kraass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8992976
    Abstract: A pharmaceutical composition is provided according to the invention which is suited for the production of tablets by direct compression and which contains donepezil hydrochloride of polymorphic form I. The polymorphic form I of donepezil hydrochloride in the directly compressed tablet is also stable during long storage.
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: March 31, 2015
    Assignee: ratiopharm, GmbH
    Inventors: Julia Schulze Nahrup, Frank Muskulus, Peter Kraass
  • Patent number: 8309607
    Abstract: The present invention relates to an irbesartan-containing pharmaceutical composition, in particular a tablet thereof, which comprises the active ingredient, a disintegrant with at least one low-substituted hydroxypropyl cellulose.
    Type: Grant
    Filed: February 13, 2007
    Date of Patent: November 13, 2012
    Assignee: ratiopharm GmbH
    Inventors: Julia Schulze Nahrup, Sandra Brueck, Rainer Alles, Peter Kraass
  • Publication number: 20090220597
    Abstract: The present invention relates to an irbesartan-containing pharmaceutical composition, in particular a tablet thereof, which comprises the active ingredient, a disintegrant with at least one low-substituted hydroxypropyl cellulose.
    Type: Application
    Filed: February 13, 2007
    Publication date: September 3, 2009
    Applicant: Ratiopharm GmbH
    Inventors: Julia Schulze Nahrup, Sandra Brueck, Rainer Alles, Peter Kraass
  • Publication number: 20050203186
    Abstract: The invention relates to a medicament containing at least one active ingredient which lowers the cholesterol in the blood, characterized in that it has means for providing release characteristics for the active ingredient with which the active ingredient is released with at least two different release rates, specifically with a first release rate in a first period and with a second release rate, which is higher than the first release rate, in a subsequent second period, where the second period starts 2 to 12 hours after administration of the medicament.
    Type: Application
    Filed: March 6, 2003
    Publication date: September 15, 2005
    Inventor: Peter Kraass